Coherus Oncology, Inc. (CHRS): Total Liabilities
$197.33M
As of 2025-12-31
$130.34M
As of 2026-06-30
-31.7%
3-year compound annual growth
-18.8%
5-year compound annual growth
-1.1%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $197.33M | -66.0% | 2026-03-09, Balance as of period end |
| 2024-12-31 | $580.52M | -29.5% | 2026-03-09, Balance as of period end |
| 2023-12-31 | $823.03M | +33.1% | 2025-03-17, Balance as of period end |
| 2022-12-31 | $618.26M | +6.3% | 2024-03-15, Balance as of period end |
| 2021-12-31 | $581.61M | +3.7% | 2023-03-06, Balance as of period end |
| 2020-12-31 | $560.67M | +84.6% | 2022-02-23, Balance as of period end |
| 2019-12-31 | $303.71M | +120.0% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $138.06M | +4.5% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $132.08M | -17.0% | 2019-02-28, Balance as of period end |
| 2016-12-31 | $159.13M | -27.4% | 2018-03-08, Balance as of period end |
| 2015-12-31 | $219.31M | +82.1% | 2017-03-14, Balance as of period end |
| 2014-12-31 | $120.46M | +34.1% | 2016-02-29, Balance as of period end |
| 2013-12-31 | $89.83M | n/a | 2015-03-23, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | 2025-12-31 | $197.33M | -66.0% |
| Tectonic Therapeutic, Inc. (TECX) | 2025-12-31 | $9.71M | -20.0% |
| Voyager Therapeutics, Inc. (VYGR) | 2025-12-31 | $56.20M | -39.8% |
| Lexeo Therapeutics, Inc. (LXEO) | 2025-12-31 | $22.02M | -26.8% |
| Adaptimmune Therapeutics PLC (ADAPY) | 2024-12-31 | $234.11M | -3.7% |
| MeiraGTx Holdings plc (MGTX) | 2025-12-31 | $250.22M | +23.9% |
| Invivyd, Inc. (IVVD) | 2025-12-31 | $35.34M | -43.0% |
| DBV Technologies S.A. (DBVT) | 2025-12-31 | $64.95M | +69.7% |
| Solid Biosciences Inc. (SLDB) | 2025-12-31 | $52.53M | +2.2% |
Compare CHRS, TECX, VYGR, LXEO side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗